These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 30895192)

  • 1. Killing Two Angry Birds with One Stone: Autophagy Activation by Inhibiting Calpains in Neurodegenerative Diseases and Beyond.
    Weber JJ; Pereira Sena P; Singer E; Nguyen HP
    Biomed Res Int; 2019; 2019():4741252. PubMed ID: 30895192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of calpain activation in neurodegenerative processes.
    Camins A; Verdaguer E; Folch J; Pallàs M
    CNS Drug Rev; 2006; 12(2):135-48. PubMed ID: 16958987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain-2 as a therapeutic target for acute neuronal injury.
    Wang Y; Bi X; Baudry M
    Expert Opin Ther Targets; 2018 Jan; 22(1):19-29. PubMed ID: 29168923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
    Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
    J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct mechanistic roles of calpain and caspase activation in neurodegeneration as revealed in mice overexpressing their specific inhibitors.
    Higuchi M; Tomioka M; Takano J; Shirotani K; Iwata N; Masumoto H; Maki M; Itohara S; Saido TC
    J Biol Chem; 2005 Apr; 280(15):15229-37. PubMed ID: 15699033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulators of calpain activity: inhibitors and activators as potential drugs.
    Dókus LE; Yousef M; Bánóczi Z
    Expert Opin Drug Discov; 2020 Apr; 15(4):471-486. PubMed ID: 32022614
    [No Abstract]   [Full Text] [Related]  

  • 7. Caspase and calpain substrates: roles in synaptic plasticity and cell death.
    Chan SL; Mattson MP
    J Neurosci Res; 1999 Oct; 58(1):167-90. PubMed ID: 10491581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpains as a target for therapy of neurodegenerative diseases: putative role of lithium.
    Camins A; Crespo-Biel N; Junyent F; Verdaguer E; Canudas AM; Pallàs M
    Curr Drug Metab; 2009 Jun; 10(5):433-47. PubMed ID: 19689241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration.
    Ray SK; Banik NL
    Curr Drug Targets CNS Neurol Disord; 2003 Jun; 2(3):173-89. PubMed ID: 12769798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of the calpain family: new aspects.
    Saez ME; Ramirez-Lorca R; Moron FJ; Ruiz A
    Drug Discov Today; 2006 Oct; 11(19-20):917-23. PubMed ID: 16997142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calpain.
    Perrin BJ; Huttenlocher A
    Int J Biochem Cell Biol; 2002 Jul; 34(7):722-5. PubMed ID: 11950589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961.
    Sandmann S; Prenzel F; Shaw L; Schauer R; Unger T
    Br J Pharmacol; 2002 Apr; 135(8):1951-8. PubMed ID: 11959798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The calpains in aging and aging-related diseases.
    Nixon RA
    Ageing Res Rev; 2003 Oct; 2(4):407-18. PubMed ID: 14522243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy in neurodegenerative diseases: from mechanism to therapeutic approach.
    Nah J; Yuan J; Jung YK
    Mol Cells; 2015 May; 38(5):381-9. PubMed ID: 25896254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpains and human disease.
    Bertipaglia I; Carafoli E
    Subcell Biochem; 2007; 45():29-53. PubMed ID: 18193633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy.
    Shacka JJ; Roth KA; Zhang J
    Front Biosci; 2008 Jan; 13():718-36. PubMed ID: 17981582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled cortical impact-induced neurodegeneration decreases after administration of the novel calpain-inhibitor Gabadur.
    Dugue R; Hassen GW; Shulman A; Goodman JH; Michelson H; Serrano P; Chauhan S; Ling DSF
    Brain Res Bull; 2018 Sep; 142():368-373. PubMed ID: 30149198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular dynamic simulations of the catalytic subunit of calpains 1, 2, 5, and 10: Structural analysis with an aim toward drug design.
    Romo-Mancillas A; Lemus R; Pérez-Estrada R; Kuribreña-Romero de Terreros F; Domínguez-Ramírez L
    Chem Biol Drug Des; 2019 Jan; 93(1):38-49. PubMed ID: 30107087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calpains: intact and active?
    Johnson GV; Guttmann RP
    Bioessays; 1997 Nov; 19(11):1011-8. PubMed ID: 9394623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-nitrosation of calpains is associated with cardioprotection in myocardial I/R injury.
    Totzeck M; Korste S; Miinalainen I; Hendgen-Cotta UB; Rassaf T
    Nitric Oxide; 2017 Jul; 67():68-74. PubMed ID: 28392447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.